Breeze Meds vs Hers: Which GLP-1 Provider Is Better?
Short answer: Breeze Meds scores higher on our rubric, 7.3/10 against 5.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Breeze Meds beats Hers overall, scoring 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Hers is $188 first month, then $298/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
A side-by-side look at Breeze Meds and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Breeze Meds
#26 of 54Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsHers
#44 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit Hers| Feature | Breeze Meds | Hers |
|---|---|---|
| Why each one | No subscription required, pay per order rather than committing to recurring billing, with four GLP-1 formulations including oral dissolving tablets. | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. |
| Our Score | 7.3/10 | 5.3/10 |
| Headline Price | from $199/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want to order compounded GLP-1s month-by-month with no subscription commitment | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path |
| Watch out for | No terms of service is published anywhere on the site, even though the privacy policy says your use of the platform is governed by one. The FAQ questions about cost, insurance and shipping are answered with unrelated text, so shipping cost and insurance acceptance are never actually stated (checked 2026-09-03). | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). |
| Ranking | #26 | #44 |
| Get started | Visit Breeze Meds | Visit Hers |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required, order on demand without recurring billing commitments
- +Four GLP-1 formulations: injectable semaglutide, injectable tirzepatide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −No terms of service is published anywhere on the site, even though the privacy policy says your use of the platform is governed by one. The FAQ questions about cost, insurance and shipping are answered with unrelated text, so shipping cost and insurance acceptance are never actually stated (checked 2026-09-03).
- −Only the semaglutide injection sits at the $199 floor. Oral semaglutide starts at $299 and both tirzepatide options, tablet and injection, start at $399 on the homepage pricing grid, so a tablet only costs extra if you want semaglutide.
- −The medical team named on the site, Lion MD led by Dr. Ana Lisa Carr and Dr. Kelly Tenbrink, is the same clinical leadership named by CareBareRX, so shopping the two against each other does not get you a second independent option.
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Breeze Meds edges out Hers with a score of 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Breeze Meds and Hers start above the cheapest complete recurring program we track. Across all 54 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Breeze Meds and Hers.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Breeze Meds and Direct Meds GLP-1from $297/mo
- Compare Breeze Meds and SnagRxpublished $99/mo; total not verified
- Compare Breeze Meds and MyStart Healthfrom $299/mo
- Compare Hers and Fridaysfrom $117/mo
- Compare Hers and Eden Health GLP-1$99/mo month-to-month
- Compare Hers and TrimRxpublished $149/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Breeze Meds · 7.3/10